Read Answer
Asked by Elaine or Gerry on March 28, 2016
Q: Hi. What is your opinion of Skyworks Solutions? Also I was wondering what the analysts'’ 3-yr projected revenue and eps increases are for it? Thanks, JR
Q: Hi 5i: Over the years I have heard several advisors on BNN say that Unilever is a good way to access emerging markets. I just checked RBC Direct and found 5 or 6 different codes for Unilever (including UN and UL) and am not sure which I should buy (if I buy). Could you advise? And what do you think of the Unilever for EM thesis? Thanks
Q: This shipping has been beaten up so BADLY and the yield is so compelling. I know probably shipping companies were suffering from historic low volume of global trade, but what is your guys' thoughts on it. I am more like a conservative income investor, so I think why don't buy a bunch of companies at low prices while gauging 12% a year? Sound like a good idea. Please give me your thoughts. Much appreciated!!! Tao
Q: Hello 5i team,
If it is in your mandate, I would appreciate some precision on the options strategy that you proposed. I Have been using it and doing quite well. Recently my option for Calm was assigned at $52.50. The price today is about $51.50, or so. I notice that the price swings of Calm can be quite large. So, my question is whether I should wait for one of these swings, letting it go to say, $49 or $48 before buying again and selling an option? or, would I be better to simply buy when the option is assigned and start all over again, not waiting for the fall in price?
thanks
Q: For a diversified portfolio, would you choose DFS or FNV for roughly a three year hold? Thank you again for your careful answers to members' questions.
Q: I hold JPM and INVN in my US portfolio. INVN has not done much and JPM seems to be too dependent on the Fed.
What is your opinion on these two stocks and would I be better off selling these two and buying GILD.
(also own BRK.B, CVS, INTC, IWO, QQQ, VIG in my US account)
I have holdings largely in line with the balanced equity portfolio. I've been considering adding some US stocks like SBUX, APPL, etc., but I have a question. If one holds the BE portfolio, is there really a need to add more US/global names? It seems the names in the BE portfolio have well diversified earnings sources and do business all over the world. Are we really adding anything with the out-of-Canada stocks?
Q: AMGN seems to have a broader range of products on the market than GILD which appears to be hepatitis-c drug weighted, so why is AMGN not the better stock to purchase in your view? Thanks for your take vis-a-vis these two US stocks.
Q: I have 50k in ZDV and 50K in ZPR, now wondering what to do with additional money I want to contribute on a weekly/monthly basis. I am thinking of adding XEI,or ZRE but not sure. I like continuous income that I can re-invest while my underlying security rises. I was also thinking of investing for international diversification but I will not get the dividend tax advantage, so also looking at taxes. I can always continue to add to my existing positions, sitting on the fence not knowing which side to go. Any suggestions for a middle aged man.
Q: Could you have a look at this and offer a comment on the merger price of $13.00 and the current share price of $11.71. With an April 1 closing seems like quick 10% upside.
Q: Two past Seeking Alpha recommendations have shown up on my radar, both of which have been beaten down but seem to be making a comeback. SRPT is in the medical field and is known to fail drug tests. HCLP is indirectly involved with oil fracking in the sand business. Both are moving up fast. Is it worth getting in for a short ride? Thanks, Dennis
Q: Hi, I was wondering what the analysts’ 3-yr projected revenue and eps increases are for mondelez international. Also, what is your opinion on of this company in a well-diversified portfolio (buy, sell or hold). Thanks. JR